Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement

Author： Capalbo Silvana   Chiefa Antonia   Delia Mario   Diomede Daniela   Liso Vincenzo  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.2, 2007-01, pp. : 262-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome

By Chim C.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 181-182

Springer Publishing Company

Access to resources Recommend Favorite

Plasma cell leukemia: advantages of treatment with bortezomib

By Fraimout N.  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite

Osteolytic lesions marker in multiple myeloma

By Djunic Irena  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 237-240

Humana Press, Inc

Access to resources Recommend Favorite

CD7 promotes extramedullary involvement of the B-cell acute lymphoblastic leukemia line Tanoue by enhancing integrin β2-dependent cell adhesiveness

By            

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1073-1081

Spandidos Publications

Access to resources Recommend Favorite

Hairy cell leukemia in a patient with situs inversus totalis: an extremely rare combination

By Pathak Prajwol   Zilberman Valeria   Avezbakiyev Boris   Gotlieb Vladimir  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 753-756

Future Medicine

Access to resources Recommend Favorite